Cantor raises Solid Biosciences stock price target on gene therapy
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
The policymaker stopped just short of calling for an interest rate hike.